CPHI - China Pharma Holdings, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 512.01M
Enterprise Value 320.52M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.03
Price/Book (mrq)0.39
Enterprise Value/Revenue 31.76
Enterprise Value/EBITDA 6-21.18

Trading Information

Stock Price History

Beta (3Y Monthly) 1.53
52-Week Change 318.38%
S&P500 52-Week Change 36.52%
52 Week High 30.8400
52 Week Low 30.1900
50-Day Moving Average 30.2869
200-Day Moving Average 30.3072

Share Statistics

Avg Vol (3 month) 3351.37k
Avg Vol (10 day) 3252.66k
Shares Outstanding 543.58M
Float 21.94M
% Held by Insiders 149.66%
% Held by Institutions 12.04%
Shares Short (Jun 28, 2019) 45.26k
Short Ratio (Jun 28, 2019) 40.01
Short % of Float (Jun 28, 2019) 40.02%
Short % of Shares Outstanding (Jun 28, 2019) 40.01%
Shares Short (prior month May 31, 2019) 4546

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 221804/1000
Last Split Date 3Aug 15, 2003

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -93.39%
Operating Margin (ttm)-35.74%

Management Effectiveness

Return on Assets (ttm)-4.84%
Return on Equity (ttm)-28.97%

Income Statement

Revenue (ttm)11.64M
Revenue Per Share (ttm)0.27
Quarterly Revenue Growth (yoy)-19.00%
Gross Profit (ttm)1.97M
EBITDA -969.09k
Net Income Avi to Common (ttm)-10.87M
Diluted EPS (ttm)-0.2500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)961.28k
Total Cash Per Share (mrq)0.02
Total Debt (mrq)9.1M
Total Debt/Equity (mrq)29.73
Current Ratio (mrq)0.89
Book Value Per Share (mrq)0.70

Cash Flow Statement

Operating Cash Flow (ttm)823.78k
Levered Free Cash Flow (ttm)3.89M